Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson's disease.
about
Novel subcellular localization for α-synuclein: possible functional consequencesChemical Compensation of Mitochondrial Phospholipid Depletion in Yeast and Animal Models of Parkinson's DiseaseAlpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.The citicoline brain injury treatment (COBRIT) trial: design and methods.Brain arachidonic acid cascade enzymes are upregulated in a rat model of unilateral Parkinson diseasePhosphatidylethanolamine deficiency disrupts α-synuclein homeostasis in yeast and worm models of Parkinson diseaseSevere alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease.Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans.In vivo imaging of disturbed pre- and post-synaptic dopaminergic signaling via arachidonic acid in a rat model of Parkinson's diseasePGE2 EP1 receptor deletion attenuates 6-OHDA-induced Parkinsonism in mice: old switch, new target.Role of phosphatidylcholine during neuronal differentiation.Molecular changes in the postmortem parkinsonian brain.Ethanolamine and Phosphatidylethanolamine: Partners in Health and Disease.Mitochondrial Dysfunction: The Road to Alpha-Synuclein Oligomerization in PD.Melittin stimulates fatty acid release through non-phospholipase-mediated mechanisms and interacts with the dopamine transporter and other membrane-spanning proteins.D-Amphetamine stimulates D2 dopamine receptor-mediated brain signaling involving arachidonic acid in unanesthetized rats.
P2860
Q26827605-4181D90A-89AC-4220-B835-71BCAF51FF09Q28554706-C308CA2D-9FFA-4894-8234-5881EA331916Q30856480-C47963BF-C11E-4E86-BA15-BE19CA03B8C2Q33666576-14B3F84F-A2D7-430B-BC5F-75B0847F8D3BQ33718730-122499A5-DE70-42FA-8045-687408499ABFQ34281004-7FE3194D-DC24-4985-9A3E-09B7A9FF1689Q35287117-62213222-087D-4F4D-AA35-D3663F91A78EQ35742545-73A53F40-4309-4614-9181-225DFB2E91BBQ36089003-446D4923-72D9-4ADC-9FC5-5EA091A321B5Q36424324-A13846BD-54CA-4710-8B44-83FC52EE26A5Q37912102-DD2D0937-5D88-4CE3-B8B8-329AD5CF44E3Q38887346-A29B75BC-268F-412E-AC09-174E3406F7B1Q41141822-85DA4A58-A451-4277-8D18-C88F8812C296Q42580316-DD86C932-F5C1-4F3E-BB26-D3F19F5C9FFEQ42777714-53244BB3-D356-4C7D-9A98-BE4810B7C4CBQ46971491-7D5BEEBC-6034-4635-A070-A974E763F947
P2860
Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson's disease.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Elevated activity of phospholi ...... ents with Parkinson's disease.
@ast
Elevated activity of phospholi ...... ents with Parkinson's disease.
@en
type
label
Elevated activity of phospholi ...... ents with Parkinson's disease.
@ast
Elevated activity of phospholi ...... ents with Parkinson's disease.
@en
prefLabel
Elevated activity of phospholi ...... ents with Parkinson's disease.
@ast
Elevated activity of phospholi ...... ents with Parkinson's disease.
@en
P2093
P1433
P1476
Elevated activity of phospholi ...... ients with Parkinson's disease
@en
P2093
P304
P356
10.1016/S0306-4522(00)00501-7
P407
P577
2001-01-01T00:00:00Z